🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Oral polio and rotavirus vaccines are significantly less effective in child...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2011-05
Trial ID
NCT01375647
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The proposed project seeks to implement a cluster-randomized controlled tri...
Status
Completed
Location
World Food Programme Colombia
Start Date
2016-04-02
Trial ID
NCT03210454
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00092469
The study will assess and compare the immune response to full-dose inactiva...
Status
Completed
Location
Hospital Universitario Nuestra Señora de la Alta Gracia
Start Date
2017-10-23
Trial ID
NCT03239496
The purpose of this study is to evaluate the safety of sIPVs of different d...
Status
Completed
Location
Pizhou City Center for Disease Control and Prevention
Start Date
2016-10
Trial ID
NCT02985320
Treatments Being Tested
Primary objectives: To demonstrate that REPEVAX and VAXIGRIP administered ...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site
Start Date
2010-10
Trial ID
NCT01249183
Treatments Being Tested